Pharmaids Pharmaceuticals Live BSE/NSE | Pharmaids Pharmaceuticals Fundamenta data | Pharmaids Pharmaceuticals Balance sheet | Pharmaids Pharmaceuticals Quarterly Results | Pharmaids Pharmaceuticals Profit & Loss | Pharmaids Pharmaceuticals Financial Ratios

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

12.63
57.41
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

12.61
N/A
1.48

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

-100.00
-100.00
-100.00

EBITDA CAGR (%)

10 Years
5 Years
3 Years

21.13
-0.58
-2.71

PAT CAGR (%)

10 Years
5 Years
3 Years

P:E (Median)

8 Years
5 Years
3 Years

-
-
39.72

P:BV (Average)

8 Years
5 Years
3 Years

1.11
1.11
1.11

EV:EBITDA (Average)

8 Years
5 Years
3 Years

3.53
-19.95
-35.16

Quarterly Results

Standalone Figures in Rs. Crores

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 3.26 -0.01 - 0.00 0.01 -100.00% 0.00 0.02 -100.00% 0.00 0.51 -100.00%
Expenses 3.20 0.06 5,233.33% 0.01 0.07 -85.71% 0.03 0.07 -57.14% 0.18 0.45 -60.00%
EBITDA 0.06 -0.07 - -0.01 -0.06 - -0.03 -0.04 - -0.18 0.06 -
EBIDTM 1.84% 558.33% 0.00% -491.67% -0.29% -187.50% 0.00% 11.39%
Other Income 0.00 0.00 0.00 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.01 0.01 0.00% 0.01 0.01 0.00% 0.01 0.01 0.00% 0.01 0.02 -50.00%
PBT 0.05 -0.08 - 0.00 -0.07 - -0.04 -0.06 - -0.19 0.04 -
Tax 0.01 0.00 0.00 0.00 0.00 0.00 -0.41 0.03 - 0.00 0.00 0.00
PAT 0.04 -0.08 - 0.00 -0.07 - 0.37 -0.09 - -0.19 0.04 -
PATM 1.17% 658.33% 0.00% -558.33% 2.87% -370.83% 0.00% 8.05%
EPS 0.04 -0.08 - 0.00 -0.07 - 0.36 -0.09 - -0.19 0.04 -

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 3.26 0.00 0.56 0.45 1.20 1.68 1.73 1.41 1.27 1.24 0.78 Net Sales Growth 515.09% -100% 24.44% -62.50% -28.57% -2.89% 22.70% 11.02% 2.42% 58.97% Cost Of Goods Sold 502.25 0.00 0.36 0.50 0.67 1.16 1.03 0.98 0.85 0.79 0.65 Gross Profit -498.99 0.00 0.20 -0.05 0.53 0.53 0.69 0.42 0.42 0.44 0.13 GP Margin -15,306.35% 0 35.71% -11.11% 44.17% 31.55% 39.88% 29.79% 33.07% 35.48% 16.67% Total Expenditure 3.42 0.34 0.66 0.84 1.55 2.03 1.82 1.84 1.20 1.10 0.83 Power & Fuel Cost - 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.01 0.01 0.00 % Of Sales - 0 0% 0% 0.83% 0.60% 0.58% 0% 0.79% 0.81% 0% Employee Cost - 0.02 0.05 0.06 0.17 0.20 0.18 0.10 0.09 0.08 0.03 % Of Sales - 0 8.93% 13.33% 14.17% 11.90% 10.40% 7.09% 7.09% 6.45% 3.85% Manufacturing Exp. - 0.01 0.00 0.01 0.08 0.09 0.06 0.06 0.06 0.02 0.01 % Of Sales - 0 0% 2.22% 6.67% 5.36% 3.47% 4.26% 4.72% 1.61% 1.28% General & Admin Exp. - 0.28 0.15 0.21 0.19 0.24 0.21 0.17 0.12 0.11 0.07 % Of Sales - 0 26.79% 46.67% 15.83% 14.29% 12.14% 12.06% 9.45% 8.87% 8.97% Selling & Distn. Exp. - 0.02 0.09 0.06 0.11 0.15 0.16 0.18 0.07 0.09 0.06 % Of Sales - 0 16.07% 13.33% 9.17% 8.93% 9.25% 12.77% 5.51% 7.26% 7.69% Miscellaneous Exp. - 0.00 0.01 0.00 0.32 0.18 0.16 0.35 0.00 0.01 0.06 % Of Sales - 0 1.79% 0% 26.67% 10.71% 9.25% 24.82% 0% 0.81% 0% EBITDA -0.16 -0.34 -0.10 -0.39 -0.35 -0.35 -0.09 -0.43 0.07 0.14 -0.05 EBITDA Margin -4.91% 0 -17.86% -86.67% -29.17% -20.83% -5.20% -30.50% 5.51% 11.29% -6.41% Other Income 0.03 0.00 0.01 0.02 0.01 0.05 0.12 0.16 0.05 0.00 0.00 Interest 0.00 0.00 0.00 0.00 0.04 0.03 0.00 0.01 0.01 0.04 0.00 Depreciation 0.04 0.04 0.05 0.00 0.06 0.10 0.14 0.08 0.07 0.08 0.08 PBT -0.18 -0.38 -0.14 -0.37 -0.44 -0.43 -0.11 -0.37 0.04 0.02 -0.12 Tax -0.40 -0.41 0.03 0.02 -0.03 -0.03 -0.04 -0.01 -0.01 -0.01 -0.01 Tax Rate 222.22% 107.89% -21.43% -5.41% -37.50% 6.98% 36.36% 2.70% -25.00% -50.00% 7.69% PAT 0.22 0.03 -0.18 -0.39 0.11 -0.40 -0.07 -0.35 0.05 0.04 -0.12 PAT before Minority Interest 0.22 0.03 -0.18 -0.39 0.11 -0.40 -0.07 -0.35 0.05 0.04 -0.12 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.75% 0 -32.14% -86.67% 9.17% -23.81% -4.05% -24.82% 3.94% 3.23% -15.38% PAT Growth 210.00% 116.67% 53.85% -454.55% 127.50% -471.43% 80.0% -800% 25.00% 133.33% Unadjusted EPS 0.21 0.03 -0.17 -0.38 0.11 -0.39 -0.07 -0.34 0.05 0.04 -0.12

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

3.26

0.00

0.56

0.45

1.20

1.68

1.73

1.41

1.27

1.24

0.78

Net Sales Growth

515.09%

-100%

24.44%

-62.50%

-28.57%

-2.89%

22.70%

11.02%

2.42%

58.97%

Cost Of Goods Sold

502.25

0.00

0.36

0.50

0.67

1.16

1.03

0.98

0.85

0.79

0.65

Gross Profit

-498.99

0.00

0.20

-0.05

0.53

0.69

0.42

0.44

0.13

GP Margin

-15,306.35%

35.71%

-11.11%

44.17%

31.55%

39.88%

29.79%

33.07%

35.48%

16.67%

Total Expenditure

3.42

0.34

0.66

0.84

1.55

2.03

1.82

1.84

1.20

1.10

0.83

Power & Fuel Cost

0.00

0.01

0.00

0.01

0.00

% Of Sales

0.83%

0.60%

0.58%

0.79%

0.81%

Employee Cost

0.02

0.05

0.06

0.17

0.20

0.18

0.10

0.09

0.08

0.03

% Of Sales

8.93%

13.33%

14.17%

11.90%

10.40%

7.09%

6.45%

3.85%

Manufacturing Exp.

0.01

0.00

0.01

0.08

0.09

0.06

0.02

0.01

% Of Sales

2.22%

6.67%

5.36%

3.47%

4.26%

4.72%

1.61%

1.28%

General & Admin Exp.

0.28

0.15

0.21

0.19

0.24

0.21

0.17

0.12

0.11

0.07

% Of Sales

26.79%

46.67%

15.83%

14.29%

12.14%

12.06%

9.45%

8.87%

8.97%

Selling & Distn. Exp.

0.02

0.09

0.06

0.11

0.15

0.16

0.18

0.07

0.09

0.06

% Of Sales

16.07%

13.33%

9.17%

8.93%

9.25%

12.77%

5.51%

7.26%

7.69%

Miscellaneous Exp.

0.00

0.01

0.00

0.32

0.18

0.16

0.35

0.00

0.01

0.06

% Of Sales

1.79%

26.67%

10.71%

9.25%

24.82%

0.81%

EBITDA

-0.16

-0.34

-0.10

-0.39

-0.35

-0.09

-0.43

0.07

0.14

-0.05

EBITDA Margin

-4.91%

-17.86%

-86.67%

-29.17%

-20.83%

-5.20%

-30.50%

5.51%

11.29%

-6.41%

Other Income

0.03

0.00

0.01

0.02

0.01

0.05

0.12

0.16

0.05

0.00

Interest

0.00

0.04

0.03

0.00

0.01

0.04

0.00

Depreciation

0.04

0.05

0.00

0.06

0.10

0.14

0.08

0.07

0.08

PBT

-0.18

-0.38

-0.14

-0.37

-0.44

-0.43

-0.11

-0.37

0.04

0.02

-0.12

Tax

-0.40

-0.41

0.03

0.02

-0.03

-0.04

-0.01

Tax Rate

222.22%

107.89%

-21.43%

-5.41%

-37.50%

6.98%

36.36%

2.70%

-25.00%

-50.00%

7.69%

PAT

0.22

0.03

-0.18

-0.39

0.11

-0.40

-0.07

-0.35

0.05

0.04

-0.12

PAT before Minority Interest

0.22

0.03

-0.18

-0.39

0.11

-0.40

-0.07

-0.35

0.05

0.04

-0.12

Minority Interest

0.00

PAT Margin

6.75%

-32.14%

-86.67%

9.17%

-23.81%

-4.05%

-24.82%

3.94%

3.23%

-15.38%

PAT Growth

210.00%

116.67%

53.85%

-454.55%

127.50%

-471.43%

80.0%

-800%

25.00%

133.33%

Unadjusted EPS

0.21

0.03

-0.17

-0.38

0.11

-0.39

-0.07

-0.34

0.05

0.04

-0.12

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 8.43 8.40 1.04 1.43 1.32 1.72 1.81 2.17 2.12 2.08 Share Capital 10.27 10.27 3.36 3.36 3.36 3.36 3.36 3.36 3.36 3.36 Total Reserves -1.84 -1.87 -2.32 -1.94 -2.05 -1.65 -1.55 -1.19 -1.25 -1.28 Non-Current Liabilities -0.35 0.06 0.03 0.09 0.30 0.27 0.44 0.45 0.36 0.38 Secured Loans 0.00 0.00 0.00 0.00 0.20 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.07 0.21 0.34 0.34 0.24 0.24 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 0.03 0.20 0.23 0.50 0.68 0.54 0.64 0.56 0.61 0.97 Trade Payables 0.01 0.16 0.18 0.45 0.44 0.41 0.53 0.38 0.26 0.20 Other Current Liabilities 0.01 0.04 0.04 0.05 0.03 0.04 0.09 0.08 0.06 0.01 Short Term Borrowings 0.00 0.00 0.00 0.00 0.21 0.09 0.02 0.11 0.30 0.76 Short Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Total Liabilities 8.11 8.66 1.30 2.02 2.30 2.53 2.89 3.18 3.09 3.43 Net Block 0.08 0.08 0.00 0.00 0.44 0.46 0.62 0.69 0.62 0.69 Gross Block 0.51 0.46 0.00 0.00 2.12 2.04 2.03 2.12 1.97 1.96 Accumulated Depreciation 0.42 0.39 0.00 0.00 1.68 1.58 1.41 1.42 1.35 1.27 Non Current Assets 6.97 4.29 0.54 0.38 0.76 0.93 1.20 1.22 1.48 1.79 Capital Work in Progress 0.45 0.45 0.00 0.00 0.00 0.00 0.00 0.00 0.15 0.15 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 6.43 3.76 0.54 0.38 0.32 0.47 0.58 0.53 0.72 0.95 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1.15 4.38 0.75 1.64 1.54 1.59 1.70 1.96 1.61 1.64 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 0.00 0.00 0.00 0.24 0.29 0.29 0.28 0.22 0.18 0.15 Sundry Debtors 0.76 0.89 0.52 0.79 1.07 1.11 1.26 1.58 1.43 1.26 Cash & Bank 0.02 0.11 0.24 0.61 0.18 0.19 0.13 0.14 0.01 0.23 Other Current Assets 0.37 0.00 0.00 0.00 0.00 0.00 0.03 0.01 0.00 0.00 Short Term Loans & Adv. 0.37 3.38 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Net Current Assets 1.12 4.17 0.52 1.14 0.86 1.05 1.06 1.40 1.00 0.67 Total Assets 8.12 8.67 1.29 2.02 2.30 2.52 2.90 3.18 3.09 3.43

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

8.43

8.40

1.04

1.43

1.32

1.72

1.81

2.17

2.12

2.08

Share Capital

10.27

3.36

Total Reserves

-1.84

-1.87

-2.32

-1.94

-2.05

-1.65

-1.55

-1.19

-1.25

-1.28

Non-Current Liabilities

-0.35

0.06

0.03

0.09

0.30

0.27

0.44

0.45

0.36

0.38

Secured Loans

0.00

0.20

0.00

Unsecured Loans

0.00

0.07

0.21

0.34

0.24

Long Term Provisions

0.00

Current Liabilities

0.03

0.20

0.23

0.50

0.68

0.54

0.64

0.56

0.61

0.97

Trade Payables

0.01

0.16

0.18

0.45

0.44

0.41

0.53

0.38

0.26

0.20

Other Current Liabilities

0.01

0.04

0.05

0.03

0.04

0.09

0.08

0.06

0.01

Short Term Borrowings

0.00

0.21

0.09

0.02

0.11

0.30

0.76

Short Term Provisions

0.00

Total Liabilities

8.11

8.66

1.30

2.02

2.30

2.53

2.89

3.18

3.09

3.43

Net Block

0.08

0.00

0.44

0.46

0.62

0.69

0.62

0.69

Gross Block

0.51

0.46

0.00

2.12

2.04

2.03

2.12

1.97

1.96

Accumulated Depreciation

0.42

0.39

0.00

1.68

1.58

1.41

1.42

1.35

1.27

Non Current Assets

6.97

4.29

0.54

0.38

0.76

0.93

1.20

1.22

1.48

1.79

Capital Work in Progress

0.45

0.00

0.15

Non Current Investment

0.00

Long Term Loans & Adv.

6.43

3.76

0.54

0.38

0.32

0.47

0.58

0.53

0.72

0.95

Other Non Current Assets

0.00

Current Assets

1.15

4.38

0.75

1.64

1.54

1.59

1.70

1.96

1.61

1.64

Current Investments

0.00

Inventories

0.00

0.24

0.29

0.28

0.22

0.18

0.15

Sundry Debtors

0.76

0.89

0.52

0.79

1.07

1.11

1.26

1.58

1.43

1.26

Cash & Bank

0.02

0.11

0.24

0.61

0.18

0.19

0.13

0.14

0.01

0.23

Other Current Assets

0.37

0.00

0.03

0.01

0.00

Short Term Loans & Adv.

0.37

3.38

0.00

Net Current Assets

1.12

4.17

0.52

1.14

0.86

1.05

1.06

1.40

1.00

0.67

Total Assets

8.12

8.67

1.29

2.02

2.30

2.52

2.90

3.18

3.09

3.43

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity -0.75 -0.10 -0.21 0.33 0.02 0.21 0.08 0.17 0.28 0.12 PBT -0.38 -0.14 -0.37 0.08 -0.43 -0.11 -0.37 0.04 0.02 -0.13 Adjustment 0.04 0.04 -0.02 0.09 0.12 0.14 0.09 0.08 0.11 0.08 Changes in Working Capital -0.41 0.00 0.19 0.15 0.32 0.18 0.36 0.06 0.15 0.17 Cash after chg. in Working capital -0.75 -0.10 -0.20 0.33 0.02 0.21 0.08 0.17 0.28 0.12 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 -0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 0.66 0.00 -0.09 0.33 -0.08 -0.01 0.00 0.00 0.00 0.00 Net Fixed Assets -0.05 -0.91 0.00 2.12 -0.08 -0.01 0.09 0.00 -0.01 0.00 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.71 0.91 -0.09 -1.79 0.00 0.00 -0.09 0.00 0.01 0.00 Cash from Financing Activity 0.00 -0.03 -0.07 -0.22 0.05 -0.13 -0.09 -0.04 -0.51 0.01 Net Cash Inflow / Outflow -0.09 -0.13 -0.37 0.43 -0.01 0.06 -0.01 0.13 -0.23 0.13 Opening Cash & Equivalents 0.11 0.24 0.61 0.18 0.19 0.13 0.14 0.01 0.23 0.11 Closing Cash & Equivalent 0.02 0.11 0.24 0.61 0.18 0.19 0.13 0.14 0.01 0.23

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

-0.75

-0.10

-0.21

0.33

0.02

0.21

0.08

0.17

0.28

0.12

PBT

-0.38

-0.14

-0.37

0.08

-0.43

-0.11

-0.37

0.04

0.02

-0.13

Adjustment

0.04

-0.02

0.09

0.12

0.14

0.09

0.08

0.11

0.08

Changes in Working Capital

-0.41

0.00

0.19

0.15

0.32

0.18

0.36

0.06

0.15

0.17

Cash after chg. in Working capital

-0.75

-0.10

-0.20

0.33

0.02

0.21

0.08

0.17

0.28

0.12

Interest Paid

0.00

Tax Paid

0.00

-0.02

0.00

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

Cash From Investing Activity

0.66

0.00

-0.09

0.33

-0.08

-0.01

0.00

Net Fixed Assets

-0.05

-0.91

0.00

2.12

-0.08

-0.01

0.09

0.00

-0.01

0.00

Net Investments

0.00

Others

0.71

0.91

-0.09

-1.79

0.00

-0.09

0.00

0.01

0.00

Cash from Financing Activity

0.00

-0.03

-0.07

-0.22

0.05

-0.13

-0.09

-0.04

-0.51

0.01

Net Cash Inflow / Outflow

-0.09

-0.13

-0.37

0.43

-0.01

0.06

-0.01

0.13

-0.23

0.13

Opening Cash & Equivalents

0.11

0.24

0.61

0.18

0.19

0.13

0.14

0.01

0.23

0.11

Closing Cash & Equivalent

0.02

0.11

0.24

0.61

0.18

0.19

0.13

0.14

0.01

0.23

Financial Ratios

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 8.21 8.18 3.10 4.25 3.92 5.10 5.40 6.45 6.30 6.19 ROA 0.40% -3.56% -23.27% 5.08% -16.50% -2.42% -11.66% 1.63% 1.13% -3.37% ROE 0.40% -3.76% -31.24% 7.99% -26.21% -3.71% -17.79% 2.38% 1.76% -5.53% ROCE -4.45% -3.02% -29.73% 7.61% -21.19% -4.99% -14.96% 1.75% 2.12% -4.17% Fixed Asset Turnover 0.00 2.40 199.51 0.00 0.81 0.85 0.68 0.62 0.63 0.40 Receivable days 0.00 457.05 529.55 282.58 236.66 249.56 368.27 430.58 397.54 585.61 Inventory Days 0.00 0.00 0.00 80.82 62.60 60.33 65.79 57.70 48.24 101.56 Payable days 308.08 111.89 269.93 148.95 90.41 105.25 111.57 95.66 75.83 72.45 Cash Conversion Cycle -308.08 345.16 259.62 214.45 208.85 204.64 322.49 392.62 369.95 614.72 Total Debt/Equity 0.00 0.00 0.00 0.00 0.36 0.17 0.20 0.20 0.25 0.48 Interest Cover -445.60 -215.25 -261.46 3.05 -14.08 -68.24 -44.20 6.44 1.59 -159.18

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

8.21

8.18

3.10

4.25

3.92

5.10

5.40

6.45

6.30

6.19

ROA

0.40%

-3.56%

-23.27%

5.08%

-16.50%

-2.42%

-11.66%

1.63%

1.13%

-3.37%

ROE

0.40%

-3.76%

-31.24%

7.99%

-26.21%

-3.71%

-17.79%

2.38%

1.76%

-5.53%

ROCE

-4.45%

-3.02%

-29.73%

7.61%

-21.19%

-4.99%

-14.96%

1.75%

2.12%

-4.17%

Fixed Asset Turnover

0.00

2.40

199.51

0.00

0.81

0.85

0.68

0.62

0.63

0.40

Receivable days

0.00

457.05

529.55

282.58

236.66

249.56

368.27

430.58

397.54

585.61

Inventory Days

0.00

80.82

62.60

60.33

65.79

57.70

48.24

101.56

Payable days

308.08

111.89

269.93

148.95

90.41

105.25

111.57

95.66

75.83

72.45

Cash Conversion Cycle

-308.08

345.16

259.62

214.45

208.85

204.64

322.49

392.62

369.95

614.72

Total Debt/Equity

0.00

0.36

0.17

0.20

0.25

0.48

Interest Cover

-445.60

-215.25

-261.46

3.05

-14.08

-68.24

-44.20

6.44

1.59

-159.18

Pharmaids Pharmaceuticals Ltd.

Trading

BSE: 524572 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Pharmaids Pharmaceuticals Ltd.

Trading

BSE: 524572 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update